Affinity DataIC50: 150nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 180nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 300nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 360nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 390nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 560nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 570nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 590nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 750nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 890nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.09E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.29E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.36E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.48E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.55E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.57E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.66E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.11E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.15E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:TP_TRANSPORTER: inhibition of Calcein-AM efflux (Calcein-AM: 0.25 uM) in CEM/VLB100 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.52E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.68E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibitory activity against Human MDR1 P-Glycoprotein ABC Transporter using leukemia CEM cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.70E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.73E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.73E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.91E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cellsMore data for this Ligand-Target Pair